This invention involves a porous device for implantation in the scleral tissue of the eye to relieve the intraocular pressure of glaucoma and a method for surgically implanting the device.

Patent
   RE35390
Priority
Aug 04 1992
Filed
Feb 17 1995
Issued
Dec 03 1996
Expiry
Dec 03 2013
Assg.orig
Entity
Large
142
8
all paid
1. A device for relieving intraocular pressure comprises a body portion and wall portions in the form of a hexahedron; at least the body portion composed of a biocompatible porous material; said device adapted to be implanted within the scleral tissue of the eye with at least one edge of the device at an opening of, with no substantial extension into, the anterior chamber and adjacent to the area where the sclera makes the transition into clear cornea of the eye; the pores of the body portion are of such size and quantity as to permit drainage of fluid from the anterior chamber to the scleral tissue without collapse of the anterior chamber.
7. A device for relieving intraocular pressure comprising a body portion constructed of a biocompatible material having flow passages therein; said flow passages selected from the group consisting of pores, openings, channels and spaces between fibers in a meshwork of fibers; said device having a substantially uniform cross-section adapted to be fitted within the scleral tissue of the eye at an area adjacent an opening of, with no substantial extension into, the anterior chamber of the eye at a first position adjacent to the area of the eye where the sclera makes the transition into clear cornea of the eye; and extending to a second position within the scleral tissue of the eye, the distance between said first and second positions defining the length of the body portion through which fluid can flow, said length being approximately six (6) millimeters; said flow passages being of such size and quantity as to permit drainage of fluid from the anterior chamber to the scleral tissue without collapse of the anterior chamber.8. A method for reducing intraocular pressure within the anterior chamber of an eye, said method comprising the following steps
a. creating a scleral flap by making an incision in the sclera of the eye substantially adjacent to the limbus of the eye;
b. excising a block of scleral tissue by making a second incision into the sclera underneath the previously produced scleral flap but extending into the cornea and entering the anterior chamber at substantially the area where sclera becomes cornea to provide a pocket in the sclera and a shelf in the cornea, c. placing a device for relieving intraocular pressure, said device comprising a body portion constructed of a biocompatible material; and having flow passages therein; said device having a first end portion and a second end portion with said flow passages therebetween; and
d. the device being placed in said pocket of the sclera with said first end portion of said device positioned in said shelf of the cornea whereby said first end portion of said body portion is in direct fluid contact with the anterior chamber of the eye without substantial extension into the anterior chamber of the eye and with the second end portion of said device positioned within the sclera of the eye to permit drainage of fluid from the anterior chamber into the scleral tissue without collapse of the anterior chamber.
2. A device as in claim 1 wherein one face of the hexahedron is said body portion has a first surface, said first surface of said body portion being sloped to overlie the opening into the anterior chamber to direct fluid from the anterior chamber into the body portion of the device.
3. A device as in claim 1 wherein at least one edge of one wall portion of the device at least one edge of one wall portion the top surface of the device is extended for anchoring the device in position.
4. A device as in claim 1 wherein the three edges of three wall portions of the top surface of the device, other than an the edge at the opening of the anterior chamber, are extended for anchoring the device in position.
5. A device as in claim 1 wherein a thin flange extends from four sides of the base of the device, the flange at the posterior side of the device being raised and held in position by extensions of the vertical walls of said device four sides of the base of device, the flange at the posterior side of the device being raised and held in position by extensions of the vertical walls of said device.
6. A method for reducing intraocular pressure comprising the steps of:
creating a scleral flap by making an incision in the sclera substantially adjacent to the limbus of the eye;
excising a block of sclera by making a second incision into the sclera underneath the previously produced scleral flap but extending into the cornea and entering the anterior chamber at substantially the area where sclera becomes cornea to provide a pocket in the sclera and a shelf in the cornea and to provide a window providing direct fluid contact with the anterior chamber of the eye;
providing a device for relieving intraocular pressure, said device comprising a body portion composed of a biocompatible porous material, said body portion comprising a first end portion and a second end portion, said body portion defining pores therethrough, said pores being of such size and quantity as to permit drainage of fluid from the anterior chamber to the scleral tissue without collapse of the anterior chamber; and
placing said device for relieving intraocular pressure the hexahedrally shaped device of claim 1 in said pocket of the sclera whereby said first end with the anterior portion of said device is positioned in said shelf of the cornea such that said first end portion is adjacent said window and is in direct fluid contact with the anterior chamber without extending substantially into the anterior chamber and whereby said second end portion is with the remaining portions of the device positioned within the sclera.

26 to allow rapid flow of fluid through the spaces 28 between the fibers. The meshwork of fibers 26 being made of a biocompatible material would be flexible. The meshwork would allow fluid flow to the vertically cut edges of the implant and the sclera.

Another way to achieve porosity would be through a system of channels 30 through the implant. A variety of patterns could be cut so as to achieve high fluid flow through the implant to the vertically cut edges. For example, a fan shaped system 32 of drilled holes or a grid pattern of drilled holes from front to back or an interlocking pattern drilled from side to side, etc. could be used. The purpose and design are such that fluid could pass through, as described above, and the implant would resist collapse from the imposed pressure.

A typical operation for inserting the preferred embodiment of the invention follows: After retrobulbar anesthesia, the superior rectus muscle is placed on a four O silk bridal suture. Following this, a conjunctival flap is raised starting at the superior rectus and working forward to This is then reflected back to the cornea. Cautery is used to obtain hemostasis and to outline the location of the placement for the implant. A rectangular area, 5 mm by 3 mm, is outlined using a 64 Beaver blade. A small groove is made on the sclera side to half the depth of the sclera. This is grasped at one corner and the flap is dissected anteriorly until the rectangular flap is completely raised in the clear cornea. At this point a 75 blade is used to make a stab incision into the anterior chamber of the eye and a 1 by 4 mm section of the cornea and trabecular meshwork are excised en bloc.

Using a lamellar dissecting blade, attention is turned to the posterior aspect of the bed of the rectangular flap. Further dissection at the base is carried posteriorly for approximately 0.5 millimeter. The implant is then placed into position in this bed with the inferior posterior flap laid into the groove that has just been created on the posterior aspect of the bed. The anterior portion is in direct communication with the anterior chamber. The scleral flap is then laid over this implant and tucked in underneath the superior flanges that are present. If necessary, a portion of the scleral flap can be excised so that the sclera lays down smoothly over the implant. The implant is then sutured to the sclera on both sides with a 10-O nylon suture through the fixation holes in the superior flange. The conjunctival tissue is then sutured back together with a 6-O-plain gut running suture.

Smith, Stewart G.

Patent Priority Assignee Title
10085633, Apr 19 2012 Alcon Inc Direct visualization system for glaucoma treatment
10188551, Mar 15 2013 Glaukos Corporation Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
10219942, Dec 03 2005 OMEGAD, LLC Eye implant devices and method and device for implanting such devices for treatment of glaucoma
10226380, Nov 14 2003 Alcon Inc Ocular pressure regulation
10271989, Mar 26 2012 Glaukos Corporation System and method for delivering multiple ocular implants
10285804, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
10285856, Aug 28 2001 Glaukos Corporation Implant delivery system and methods thereof for treating ocular disorders
10406029, Apr 07 2001 Glaukos Corporation Ocular system with anchoring implant and therapeutic agent
10485653, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
10485701, Apr 08 2002 Glaukos Corporation Devices and methods for glaucoma treatment
10485702, Apr 14 2000 Glaukos Corporation System and method for treating an ocular disorder
10492950, Apr 26 1999 Glaukos Corporation Shunt device and method for treating ocular disorders
10517759, Mar 15 2013 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
10531983, Jan 28 2009 Alcon Inc Ocular implant with stiffness qualities, methods of implantation and system
10568762, Apr 26 1999 Glaukos Corporation Stent for treating ocular disorders
10736778, Dec 31 2014 Innomedex LLC Glaucoma treatment devices and methods
10828195, Nov 10 2006 Glaukos Corporation Uveoscleral shunt and methods for implanting same
10828473, Apr 07 2001 Glaukos Corporation Ocular implant delivery system and methods thereof
10849558, Mar 13 2013 Glaukos Corporation Intraocular physiological sensor
10905590, Jan 17 2006 Alcon Inc Glaucoma treatment device
10912676, Apr 24 2012 Novartis AG Delivery system for ocular implant
10959941, May 29 2014 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
10980667, Sep 30 2015 Innomedex LLC Eye treatment devices and methods
11065154, Oct 06 2011 Bleb drainage device, ophthalmic product and methods
11116625, Sep 28 2017 Glaukos Corporation Apparatus and method for controlling placement of intraocular implants
11197780, Mar 26 2012 Glaukos Corporation System and method for delivering multiple ocular implants
11273028, Jul 11 2006 Refocus Group Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
11344448, Jan 28 2009 Alcon Inc Ocular implant with stiffness qualities, methods of implantation and system
11363951, Sep 13 2011 Glaukos Corporation Intraocular physiological sensor
11395764, Dec 03 2005 OMEGAD, LLC Eye implant devices and method and device for implanting such devices for treatment of glaucoma
11559430, Mar 15 2013 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
11786402, Jan 17 2006 Alcon Inc.; Alcon Inc Glaucoma treatment device
11839571, Jan 28 2009 Alcon Inc. Ocular implant with stiffness qualities, methods of implantation and system
5752928, Jul 14 1997 RDO Medical, Inc. Glaucoma pressure regulator
6007578, Oct 08 1997 REFOCUS GROUP, INC Scleral prosthesis for treatment of presbyopia and other eye disorders
6280468, Oct 08 1997 REFOCUS GROUP, INC Scleral prosthesis for treatment of presbyopia and other eye disorders
6299640, Oct 08 1997 REFOCUS GROUP, INC Scleral prosthesis for treatment of presbyopia and other eye disorders
6450984, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
6464724, Apr 26 1999 Glaukos Corporation Stent device and method for treating glaucoma
6524275, Apr 26 1999 Glaukos Corporation Inflatable device and method for treating glaucoma
6533768, Apr 14 2000 Regents of the University of California, The Device for glaucoma treatment and methods thereof
6595945, Jan 09 2001 BG IMPLANT, INC Glaucoma treatment device and method
6626858, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
6638239, Apr 14 2000 Glaukos Corporation Apparatus and method for treating glaucoma
6666841, May 02 2001 Glaukos Corporation Bifurcatable trabecular shunt for glaucoma treatment
6699210, Apr 27 1999 ARIZONA BOARD OF REGENTS, THE Glaucoma shunt and a method of making and surgically implanting the same
6736791, Apr 14 2000 Glaukos Corporation Glaucoma treatment device
6780164, Apr 14 2000 Glaukos Corporation L-shaped implant with bi-directional flow
6783544, Apr 26 1999 Glaukos Corporation Stent device and method for treating glaucoma
6827699, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
6827700, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
6881198, Jan 09 2001 BG IMPLANT, INC Glaucoma treatment device and method
6955656, Apr 14 2000 Glaukos Corporation Apparatus and method for treating glaucoma
6981958, May 02 2001 Glaukos Corporation Implant with pressure sensor for glaucoma treatment
6991650, Oct 08 1997 REFOCUS GROUP, INC Scleral expansion device having duck bill
7008396, Sep 03 1999 REFOCUS GROUP, INC Ophthalmic device and method of manufacture and use
7037335, Nov 19 2002 EAGLE VISION, INC Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma
7094225, May 03 2001 Glaukos Corporation Medical device and methods of use of glaucoma treatment
7135009, Apr 07 2001 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
7160264, Dec 19 2002 WOUND HEALING OF OKLAHOMA, INC Article and method for ocular aqueous drainage
7163543, Mar 15 2002 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
7186232, Mar 07 2002 Glaukos Corporation Fluid infusion methods for glaucoma treatment
7273475, May 03 2001 Glaukos Corporation Medical device and methods of use for glaucoma treatment
7297130, Apr 14 2000 Glaukos Corporation Implant with anchor
7331984, Aug 28 2001 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
7431710, Apr 08 2002 Glaukos Corporation Ocular implants with anchors and methods thereof
7488303, Sep 21 2002 Glaukos Corporation Ocular implant with anchor and multiple openings
7563241, Apr 07 2001 Glaukos Corporation Implant and methods thereof for treatment of ocular disorders
7678065, May 02 2001 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
7708711, Apr 14 2000 Dose Medical Corporation Ocular implant with therapeutic agents and methods thereof
7850637, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
7857782, Apr 07 2001 Glaukos Corporation Ocular implant delivery system and method thereof
7867186, Apr 08 2002 Glaukos Corporation Devices and methods for treatment of ocular disorders
7867205, Apr 14 2000 Glaukos Corporation Method of delivering an implant for treating an ocular disorder
7879001, Apr 08 2002 Glaukos Corporation Devices and methods for treatment of ocular disorders
7879079, Aug 28 2001 Glaukos Corporation Implant delivery system and methods thereof for treating ocular disorders
7927372, Aug 02 2007 REFOCUS GROUP, INC Scleral prosthesis having crossbars for treating presbyopia and other eye disorders
7951155, Mar 15 2002 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
8007459, Sep 21 2002 Glaukos Corporation Ocular implant with anchoring mechanism and multiple outlets
8062244, Apr 07 2001 Glaukos Corporation Self-trephining implant and methods thereof for treatment of ocular disorders
8075511, Apr 07 2001 Glaukos Corporation System for treating ocular disorders and methods thereof
8118768, Apr 07 2001 Glaukos Corporation Drug eluting ocular implant with anchor and methods thereof
8142364, May 02 2001 Glaukos Corporation Method of monitoring intraocular pressure and treating an ocular disorder
8152752, Apr 26 1999 Glaukos Corporation Shunt device and method for treating glaucoma
8273050, Apr 14 2000 Glaukos Corporation Ocular implant with anchor and therapeutic agent
8333742, Apr 14 2000 Glaukos Corporation Method of delivering an implant for treating an ocular disorder
8337445, May 03 2001 Glaukos Corporation Ocular implant with double anchor mechanism
8337550, Jul 11 2006 REFOCUS GROUP, INC Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
8348877, Apr 14 2000 Dose Medical Corporation Ocular implant with therapeutic agents and methods thereof
8388568, Apr 26 1999 Glaukos Corporation Shunt device and method for treating ocular disorders
8409277, Jul 11 2006 REFOCUS GROUP, INC Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
8506515, Nov 10 2006 Glaukos Corporation Uveoscleral shunt and methods for implanting same
8579846, Apr 07 2001 Glaukos Corporation Ocular implant systems
8617094, Mar 07 2002 Glaukos Corporation Fluid infusion methods for glaucoma treatment
8632489, Dec 22 2011 Implantable medical assembly and methods
8771217, Apr 26 1999 Glaukos Corporation Shunt device and method for treating ocular disorders
8801648, Apr 14 2000 Glaukos Corporation Ocular implant with anchor and methods thereof
8801649, Jan 17 2006 Alcon Inc Glaucoma treatment device
8808219, Apr 14 2000 Glaukos Corporation Implant delivery device and methods thereof for treatment of ocular disorders
8808220, Nov 14 2003 Alcon Inc Ocular pressure regulation
8814819, Jan 17 2006 Alcon Inc Glaucoma treatment device
8814820, Apr 14 2000 Glaukos Corporation Ocular implant with therapeutic agent and methods thereof
8882781, Mar 15 2002 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
8911496, Jul 11 2006 REFOCUS GROUP, INC Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
8945038, May 05 2003 Alcon Inc Internal shunt and method for treating glaucoma
9066782, Apr 14 2000 Dose Medical Corporation Ocular implant with therapeutic agents and methods thereof
9155654, Apr 07 2001 Glaukos Corporation Ocular system with anchoring implant and therapeutic agent
9155656, Apr 24 2012 Alcon Inc Delivery system for ocular implant
9220632, Mar 07 2002 Glaukos Corporation Fluid infusion methods for ocular disorder treatment
9241832, Apr 24 2012 Alcon Inc Delivery system for ocular implant
9301875, Apr 08 2002 Glaukos Corporation Ocular disorder treatment implants with multiple opening
9351873, Nov 14 2003 Alcon Inc Ocular pressure regulation
9381112, Oct 06 2011 Bleb drainage device, ophthalmological product and methods
9398977, Jan 17 2006 Alcon Inc Glaucoma treatment device
9421130, Jan 17 2006 Alcon Inc Glaucoma treatment device
9452044, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9480598, Sep 17 2012 Alcon Inc Expanding ocular implant devices and methods
9486310, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9492320, Apr 26 1999 Glaukos Corporation Shunt device and method for treating ocular disorders
9498324, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9504559, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9554940, Mar 26 2012 Glaukos Corporation System and method for delivering multiple ocular implants
9561131, Aug 28 2001 Glaukos Corporation Implant delivery system and methods thereof for treating ocular disorders
9572963, Apr 07 2001 Glaukos Corporation Ocular disorder treatment methods and systems
9592151, Mar 15 2013 Glaukos Corporation Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
9597230, Apr 08 2002 Glaukos Corporation Devices and methods for glaucoma treatment
9687339, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9700406, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9717588, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9730638, Mar 13 2013 Glaukos Corporation Intraocular physiological sensor
9730785, Jul 11 2006 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
9763828, Jan 28 2009 Alcon Inc Ocular implant with stiffness qualities, methods of implantation and system
9763829, Nov 14 2012 Alcon Inc Flow promoting ocular implant
9789000, Jan 17 2006 Alcon Inc Glaucoma treatment device
9789001, Apr 14 2000 Dose Medical Corporation Ocular implant with therapeutic agents and methods thereof
9827143, Apr 26 1999 Glaukos Corporation Shunt device and method for treating ocular disorders
9844462, May 05 2003 Alcon Inc Internal shunt and method for treating glaucoma
9907697, Apr 24 2012 Alcon Inc Delivery system for ocular implant
9962290, Nov 10 2006 Glaukos Corporation Uveoscleral shunt and methods for implanting same
9987163, Apr 16 2013 Alcon Inc Device for dispensing intraocular substances
9987472, Apr 07 2001 Glaukos Corporation Ocular implant delivery systems
9993368, Apr 14 2000 Glaukos Corporation System and method for treating an ocular disorder
Patent Priority Assignee Title
4037604, Jan 05 1976 SOUTH SHORE BANK, A TRUST COMPANY OF MA Artifical biological drainage device
4457757, Jul 20 1981 Device for draining aqueous humour
4521210, Dec 27 1982 WONG, VERNON G Eye implant for relieving glaucoma, and device and method for use therewith
4634418, Apr 06 1984 Hydrogel seton
4722724, Jun 23 1986 Anterior chamber tube shunt to an encircling band, and related surgical procedure
4750901, Mar 07 1986 Implant for drainage of aqueous humour
4787885, Apr 06 1984 Hydrogel seton
4936825, Apr 11 1988 Method for reducing intraocular pressure caused by glaucoma
Executed onAssignorAssigneeConveyanceFrameReelDoc
Date Maintenance Fee Events
Jun 04 1998M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Jun 04 1998M186: Surcharge for Late Payment, Large Entity.
Apr 03 2002M182: 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity.
Apr 03 2002M185: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Dec 03 19994 years fee payment window open
Jun 03 20006 months grace period start (w surcharge)
Dec 03 2000patent expiry (for year 4)
Dec 03 20022 years to revive unintentionally abandoned end. (for year 4)
Dec 03 20038 years fee payment window open
Jun 03 20046 months grace period start (w surcharge)
Dec 03 2004patent expiry (for year 8)
Dec 03 20062 years to revive unintentionally abandoned end. (for year 8)
Dec 03 200712 years fee payment window open
Jun 03 20086 months grace period start (w surcharge)
Dec 03 2008patent expiry (for year 12)
Dec 03 20102 years to revive unintentionally abandoned end. (for year 12)